Literature DB >> 30071332

Long-Term Neurocognitive Outcomes in Patients with Adult Moyamoya Disease.

Akira Nakamizo1, Toshiyuki Amano2, Yuhei Michiwaki2, Yousuke Kawano2, Takahiro Kuwashiro3, Masahiro Yasaka3, Yasushi Okada3.   

Abstract

OBJECTIVE: Neurocognitive impairment is a frequent complication of moyamoya disease in adults, but the long-term outcomes of neurocognitive function remain unclear. We evaluated neurocognitive functions in a group of patients with a history of moyamoya disease and assessed the relationship between regional cerebral blood flow (rCBF) and neurocognitive functions.
METHODS: We studied 53 patients with a history of adult moyamoya disease. Neurocognitive functions were evaluated with the Neurobehavioral Cognitive Status Examination (Cognistat) and the Frontal Assessment Battery. The relationship between rCBF and neurocognitive functions were assessed in patients for whom rCBF was measured using single-photon emission computed tomography with 123I-iodoamphetamine.
RESULTS: Patients had a history of moyamoya disease for an average of 10.6 years, with 23 patients managed conservatively and 30 managed using revascularization. Attention, memory, conceptualization, mental flexibility, and inhibitory control were impaired but with no significant difference between conservatively and surgically treated patients. Posterior cerebral artery involvement and frontal lobe infarction were not associated with neurocognitive examination scores in nonrevascularized or revascularized patients. Orientation, comprehension, calculation, conceptualization, and sensitivity to interference correlated with rCBF in the left ventral middle cerebral artery territory (P < 0.01), whereas memory correlated with rCBF in the right dorsal anterior cerebral artery territory (P < 0.01). Conceptualization also correlated with rCBF in the left dorsal anterior cerebral artery territory (P < 0.001).
CONCLUSIONS: Our findings indicate that long-standing hypoperfusion in specific brain regions can cause related neurocognitive dysfunction even in mild moyamoya disease managed conservatively.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cerebral blood flow; Cognistat; FAB; Frontal assessment battery; Moyamoya disease; Neurocognitive function

Mesh:

Year:  2018        PMID: 30071332     DOI: 10.1016/j.wneu.2018.07.179

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  5 in total

1.  Impairments in brain perfusion, executive control network, topological characteristics, and neurocognition in adult patients with asymptomatic Moyamoya disease.

Authors:  Shihao He; Ziqi Liu; Yanchang Wei; Ran Duan; Zongsheng Xu; Cai Zhang; Li Yuan; Tian Li; Ning Ma; Xin Lou; Xiaoyuan Liu; Rong Wang
Journal:  BMC Neurosci       Date:  2021-05-12       Impact factor: 3.288

2.  Cognitive Performance Profile in Pediatric Moyamoya Disease Patients and Its Relationship With Regional Cerebral Blood Perfusion.

Authors:  Jiaxi Li; Xingju Liu; Dong Zhang; Yan Zhang; Rong Wang; Jing Yuan; Jizong Zhao
Journal:  Front Neurol       Date:  2019-12-12       Impact factor: 4.003

3.  Predictors of preoperative cognitive dysfunction in adults with Moyamoya disease: a preliminary research.

Authors:  Jian Sun; Zhiyong Shi; Lebao Yu; Yujie Wen; Dong Zhang
Journal:  BMC Neurol       Date:  2022-01-06       Impact factor: 2.474

Review 4.  Cognitive Impairment in Primary and Secondary Headache Disorders.

Authors:  Olivia Begasse de Dhaem; Matthew S Robbins
Journal:  Curr Pain Headache Rep       Date:  2022-03-03

5.  Preoperative brain connectome predicts postoperative changes in processing speed in moyamoya disease.

Authors:  Mengxia Gao; Charlene L M Lam; Wai M Lui; Kui Kai Lau; Tatia M C Lee
Journal:  Brain Commun       Date:  2022-08-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.